Dermatology

>

Latest News

Weekly report: Phase 3 data for JNJ2113, expert discussions, and more

November 25th 2024

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from last week, all in one place.

New phase 3 data of JNJ-2113 for plaque psoriasis in patients aged 12 years, older | Image Credit: © SNAB - © SNAB - stock.adobe.com.
New phase 3 data of JNJ-2113 for plaque psoriasis in patients aged 12 years, older

November 20th 2024

FDA accept application for dupilumab to treat chronic spontaneous urticariaLatest revision | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA accepts application for dupilumab to treat chronic spontaneous urticaria

November 15th 2024

FDA accepts BLA resubmission for pz-cel to treat recessive dystrophic epidermolysis bullosa | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA accepts BLA resubmission for pz-cel to treat recessive dystrophic epidermolysis bullosa

November 13th 2024

FDA pushes PDUFA date of tapinarof cream, 1% for atopic dermatitis to 2025 | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA pushes PDUFA date of tapinarof cream, 1% for atopic dermatitis to 2025

November 6th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.